HealthMyne Raises $15 Million in Series B Round to Expand Commercialization EffortsNew Investment Fuels Company Mission to Bring Quantitative Imaging Decision Support (QIDS)® Platform to Hospitals Worldwide MADISON, Wis., August 1, 2018-- HealthMyne, the first company to bring multiple enhanced clinical decision support (CDS) workflow modules to Radiology and the Oncology care continuum in a single platform, raised a $15 Million Series B round to expand its global commercialization efforts. Ascension Ventures led the round, with participation from existing institutional backers Venture Investors, 4490 Ventures, and WARF.